These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 200045)
1. Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. II. Plasma lipids. Wallentin L; Larsson-Cohn U Acta Endocrinol (Copenh); 1977 Nov; 86(3):597-607. PubMed ID: 200045 [TBL] [Abstract][Full Text] [Related]
2. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785 [TBL] [Abstract][Full Text] [Related]
3. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353 [TBL] [Abstract][Full Text] [Related]
4. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
5. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation. Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855 [TBL] [Abstract][Full Text] [Related]
6. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone. Wild RA; Demers LM; Applebaum-Bowden D; Lenker R Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706 [TBL] [Abstract][Full Text] [Related]
7. Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism. Godsland IF; Crook D; Worthington M; Proudler AJ; Felton C; Sidhu M; Stevenson JC Contraception; 1993 Sep; 48(3):217-27. PubMed ID: 8222652 [TBL] [Abstract][Full Text] [Related]
8. Differential lipemic and proteinemic response to oral ethinyl estradiol and parenteral estradiol cypionate. Buckman MT; Johnson J; Ellis H; Srivastava L; Peake GT Metabolism; 1980 Sep; 29(9):803-5. PubMed ID: 7412555 [TBL] [Abstract][Full Text] [Related]
9. Lipid metabolic studies in oophorectomized women: effects induced by two different estrogens on serum lipids and lipoproteins. Silfverstolpe G; Gustafson A; Samsioe G; Svanborg A Gynecol Obstet Invest; 1980; 11(3):161-9. PubMed ID: 7439809 [TBL] [Abstract][Full Text] [Related]
10. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
11. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate. Furuhjelm M; Carlström K Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703 [TBL] [Abstract][Full Text] [Related]
12. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796 [TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay of unconjugated plasma ethynylestradiol in women given a single oral dose of ethynylestradiol or mestranol. de la Pena A; Chenault CB; Goldzieher JW Steroids; 1975 Jun; 25(6):773-80. PubMed ID: 1154455 [TBL] [Abstract][Full Text] [Related]
14. [Effect of an oral contraceptive (ethinylestradiol/D-norgestrel) on growth hormone and insulin secretion]. Hausmann L; Goebel KM; Zehner J Schweiz Med Wochenschr; 1976 Oct; 106(43):1470-4. PubMed ID: 1013665 [TBL] [Abstract][Full Text] [Related]
15. Plasma lipids and lipoprotein lipase activating property in women on three different combinations of estrogens and progestins. Mendoza SG; Kashyap ML; Echeverria Y; Zerpa A Biochem Med; 1981 Jun; 25(3):283-7. PubMed ID: 7271764 [TBL] [Abstract][Full Text] [Related]
16. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users. Kamal I; Zaki K; Rashad S Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028 [TBL] [Abstract][Full Text] [Related]
17. Effects of RU16117, an orally active weak oestrogenic compound, in postmenopausal women. Faure N; Labrie F; Olivier G; Tremblay M; Cloutier D; Lemay A; Ferland L; Azadian-Boulanger G; Bouton MM; Husson JM; Raynaud JP Maturitas; 1980 Jul; 2(2):155-68. PubMed ID: 6782429 [TBL] [Abstract][Full Text] [Related]
18. A comparative study of the metabolic effects of injectable and oral contraceptives. Liew DF; Ng CS; Heng SH; Ratnam SS Contraception; 1986 Apr; 33(4):385-94. PubMed ID: 2942334 [TBL] [Abstract][Full Text] [Related]
19. Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel + 0.030 mg ethinyloestradiol and 0.150 mg levonorgestrel + 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers. Samsioe G Contraception; 1982 May; 25(5):487-503. PubMed ID: 6213375 [No Abstract] [Full Text] [Related]
20. Comparative studies of the ethynyl estrogens used in oral contraceptives. VI. Effects with and without progestational agents on carbohydrate metabolism in humans, baboons, and beagles. Goldzieher JW; Chenault CB; De La Pena A; Dozier TS; Kraemer DC Fertil Steril; 1978 Aug; 30(2):146-53. PubMed ID: 98357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]